1. Home
  2. BSX vs BLK Comparison

BSX vs BLK Comparison

Compare BSX & BLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BSX
  • BLK
  • Stock Information
  • Founded
  • BSX 1979
  • BLK 1988
  • Country
  • BSX United States
  • BLK United States
  • Employees
  • BSX N/A
  • BLK N/A
  • Industry
  • BSX Medical/Dental Instruments
  • BLK Investment Bankers/Brokers/Service
  • Sector
  • BSX Health Care
  • BLK Finance
  • Exchange
  • BSX Nasdaq
  • BLK Nasdaq
  • Market Cap
  • BSX 138.4B
  • BLK 138.0B
  • IPO Year
  • BSX 1992
  • BLK 1999
  • Fundamental
  • Price
  • BSX $102.87
  • BLK $923.39
  • Analyst Decision
  • BSX Strong Buy
  • BLK Strong Buy
  • Analyst Count
  • BSX 23
  • BLK 13
  • Target Price
  • BSX $110.57
  • BLK $1,076.31
  • AVG Volume (30 Days)
  • BSX 7.1M
  • BLK 638.2K
  • Earning Date
  • BSX 04-23-2025
  • BLK 04-11-2025
  • Dividend Yield
  • BSX N/A
  • BLK 2.26%
  • EPS Growth
  • BSX 15.23
  • BLK 4.56
  • EPS
  • BSX 1.37
  • BLK 41.15
  • Revenue
  • BSX $17,554,000,000.00
  • BLK $20,955,000,000.00
  • Revenue This Year
  • BSX $15.77
  • BLK $16.03
  • Revenue Next Year
  • BSX $10.33
  • BLK N/A
  • P/E Ratio
  • BSX $75.08
  • BLK $22.44
  • Revenue Growth
  • BSX 19.36
  • BLK 14.23
  • 52 Week Low
  • BSX $71.88
  • BLK $752.30
  • 52 Week High
  • BSX $107.17
  • BLK $1,084.22
  • Technical
  • Relative Strength Index (RSI)
  • BSX 57.12
  • BLK 53.45
  • Support Level
  • BSX $103.10
  • BLK $906.57
  • Resistance Level
  • BSX $105.74
  • BLK $944.98
  • Average True Range (ATR)
  • BSX 1.86
  • BLK 18.58
  • MACD
  • BSX 0.42
  • BLK 4.69
  • Stochastic Oscillator
  • BSX 76.80
  • BLK 73.18

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

About BLK BlackRock Inc.

BlackRock is the largest asset manager in the world, with $11.584 trillion in assets under management at the end of March 2025. Its product mix is diverse, with 53% of managed assets in equity strategies, 26% in fixed income, 9% in multi-asset classes, 8% in money market funds, and 4% in alternatives. Passive strategies account for two thirds of long-term AUM, with the company's ETF platform maintaining a leading market share domestically and on a global basis. Product distribution is weighted more toward institutional clients, which by our calculations account for around 80% of AUM. BlackRock is geographically diverse, with clients in more than 100 countries and more than one third of managed assets coming from investors domiciled outside the US and Canada.

Share on Social Networks: